Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/8708720

Download in:

View as

General Info

PMID
8708720